A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN.
| Image |  |
|---|---|
| Description | scientific article published on 26 June 2013 |
| Author/s |
author: Jeroen van Moorselaar |
| Publication date | June 26, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |